BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10477400)

  • 21. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
    Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
    Zhang D; Li J; Jiang Z; Yu B; Tang X
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
    Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
    Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
    Geppert A; Losy J
    Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid IL-6, HSP72, and TNF-alpha in exercising humans.
    Steensberg A; Dalsgaard MK; Secher NH; Pedersen BK
    Brain Behav Immun; 2006 Nov; 20(6):585-9. PubMed ID: 16647242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis.
    Baraczka K; Pozsonyi T; Szüts I; Ormos G; Nékám K
    Acta Microbiol Immunol Hung; 2003; 50(4):339-48. PubMed ID: 14750436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of soluble TNF receptor-I in acute-type fulminant hepatitis.
    Tokushige K; Yamaguchi N; Ikeda I; Hashimoto E; Yamauchi K; Hayashi N
    Am J Gastroenterol; 2000 Aug; 95(8):2040-6. PubMed ID: 10950055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects.
    Gao IK; Scholz P; Boehme MW; Norden C; Lemmel EM
    Rheumatol Int; 2002 Jun; 22(2):45-51. PubMed ID: 12070674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
    Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus.
    Dellalibera-Joviliano R; Dos Reis ML; Cunha Fde Q; Donadi EA
    J Rheumatol; 2003 Mar; 30(3):485-92. PubMed ID: 12610806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis.
    Thangarajh M; Gomes A; Masterman T; Hillert J; Hjelmström P
    J Neuroimmunol; 2004 Jul; 152(1-2):183-90. PubMed ID: 15223251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
    Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
    J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.